David A. Siegel Intercept Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $126,873 - $237,617	12,700 Added 9.51%	146,200 $2.71 Million
Q2 2023 Aug 14, 2023	SELL	$9.17 - $19.29 $3.34 Million - $7.03 Million	-364,400 Reduced 73.19%	133,500 $1.48 Million
Q1 2023 May 15, 2023	SELL	$12.53 - $21.71 $595,175 - $1.03 Million	-47,500 Reduced 8.71%	497,900 $6.69 Million
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $1.01 Million - $1.4 Million	-86,700 Reduced 13.72%	545,400 $6.75 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $2.31 Million - $3.73 Million	189,300 Added 42.75%	632,100 $8.82 Million

Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $1.51 Million - $2.63 Million	-134,400 Reduced 23.28%	442,800 $6.12 Million
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $369,012 - $491,004	27,600 Added 5.02%	577,200 $9.39 Million
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $1.38 Million - $1.89 Million	96,700 Added 21.35%	549,600 $8.95 Million
Q3 2021 Nov 15, 2021	SELL	$12.99 - $20.47 $580,653 - $915,009	-44,700 Reduced 8.98%	452,900 $6.73 Million
Q2 2021 Aug 16, 2021	BUY	$15.46 - $24.5 $2.73 Million - $4.33 Million	176,600 Added 55.02%	497,600 $9.94 Million
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $1.63 Million - $3.19 Million	-84,400 Reduced 20.82%	321,000 $7.41 Million
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $4.27 Million - $7.41 Million	-174,400 Reduced 30.08%	405,400 $10 Million
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $2.52 Million - $3.45 Million	64,500 Added 12.52%	579,800 $24 Million
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $1.13 Million - $2.24 Million	-24,300 Reduced 4.5%	515,300 $24.7 Million
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $7.12 Million - $17.5 Million	147,200 Added 37.51%	539,600 $34 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $2 Million - $4.33 Million	34,900 Added 9.76%	392,400 $48.6 Million
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $2.22 Million - $3.04 Million	-37,800 Reduced 9.56%	357,500 $23.7 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $10.5 Million - $16.3 Million	135,000 Added 51.86%	395,300 $31.5 Million
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $11.8 Million - $15.5 Million	128,600 Added 97.65%	260,300 $29.1 Million
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $2.76 Million - $4.07 Million	32,200 Added 32.36%	131,700 $13.3 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $1.7 Million - $2.45 Million	19,200 Added 23.91%	99,500 $12.6 Million
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $4.82 Million - $6.88 Million	80,300 New	80,300 $6.74 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account